ChREBP in NASH – A liver transcription factor comes in from the cold

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Vitamin D for your patients with chronic hepatitis C?
Volume 60, Issue 5, Pages (May 2014)
Volume 63, Issue 1, Pages (July 2015)
Interrupting bile-acid handling and lipid and glucose control: Effects of colesevelam on glucose levels  Michael H. Davidson, MD  Journal of Clinical.
Volume 67, Issue 1, Pages (July 2017)
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
Acne vulgaris: The metabolic syndrome of the pilosebaceous follicle
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 47, Issue 1, Pages (July 2007)
Volume 52, Issue 3, Pages (March 2010)
NS5A inhibitors in the treatment of hepatitis C
Hedgehog signaling in the liver
Volume 66, Issue 4, Pages (April 2017)
Volume 57, Issue 5, Pages (November 2012)
Immigration and viral hepatitis
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Omega 3 – Omega 6: What is right for the liver?
Hepatitis C virus entry and glucocorticosteroids
Living donor liver transplantation: is the hype over?
Volume 64, Issue 1, Pages (January 2016)
Volume 40, Issue 3, Pages (March 2004)
Volume 55, Issue 4, Pages (October 2011)
Volume 134, Issue 2, Pages (February 2008)
NASH: a mitochondrial disease
Volume 11, Issue 5, Pages (May 2010)
Volume 61, Issue 4, Pages (October 2014)
Volume 42, Issue 6, Pages (June 2005)
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk  Jennifer H. Stern, Joseph M. Rutkowski,
Volume 80, Issue 5, Pages (September 2011)
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Daniel J. Felmlee, Thomas F. Baumert  Journal of Hepatology 
Volume 45, Issue 4, Pages (October 2006)
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Advancing hepatitis B virus entry inhibitors
Autophagy in the liver Journal of Hepatology
Cristoforo Silvestri, Vincenzo Di Marzo  Cell Metabolism 
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 134, Issue 4, Pages (April 2008)
Volume 57, Issue 5, Pages (November 2012)
Sweet Sixteenth for ChREBP: Established Roles and Future Goals
Vitamin D for your patients with chronic hepatitis C?
Olumacostat Glasaretil, a Promising Topical Sebum-Suppressing Agent that Affects All Major Pathogenic Factors of Acne Vulgaris  Bodo C. Melnik  Journal.
Figure 2 Lipid metabolism and metabolism-disrupting chemicals.
Cannabinoid signaling and liver therapeutics
Volume 50, Issue 4, Pages (April 2009)
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Volume 62, Issue 6, Pages (June 2015)
Volume 42, Issue 6, Pages (June 2005)
Fei Xiao, Jane A. McKeating, Thomas F. Baumert  Journal of Hepatology 
Signalling links in the liver: Knitting SOCS with fat and inflammation
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Volume 63, Issue 1, Pages (July 2015)
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
The Salt-Inducible Kinases: Emerging Metabolic Regulators
Shih-Yen Weng, Detlef Schuppan  Journal of Hepatology 
Presentation transcript:

ChREBP in NASH – A liver transcription factor comes in from the cold Michael R. Charlton  Journal of Hepatology  Volume 59, Issue 1, Pages 178-179 (July 2013) DOI: 10.1016/j.jhep.2013.03.011 Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Specific lipogenic effects of activation of ChREBP are shown. Glucose transporter 2 (GLUT2) mediated glucose entry into hepatocytes results in generation of xylulose-5-phosphate (X5P), which removes inhibitory phosphorylations on ChREBP-α, allowing binding of ChREBP-α to specific sequence elements. ChREBP-α may also be activated by dietary induced increase in hepatic ligands (oxysterols) for liver X receptors (LXRs). A stearoyl-CoA desaturase (SCD1) and Elovl6 are expressed, with a net effect of proportionally greater synthesis of mono-unsaturated fats (MUFA), oleic acid, and triglycerides (TGs), than palmitate (PALM). The relative decrease in PALM concentration decreases CAAT/enhancer binding homologous protein (CHOP) activation. Decreased PALM concentration also leads to increased Akt phosphorylation with subsequently enhanced energy production and insulin sensitivity. Journal of Hepatology 2013 59, 178-179DOI: (10.1016/j.jhep.2013.03.011) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions